Vapelabs highlights three recurring concerns from pharmacists — concerns that speak not only to professional responsibility, but to how seriously pharmacists take patient care:
1. “We’re not vape shops — we’re healthcare professionals.”
Many pharmacists' express discomfort with the idea of ‘selling’ vape products. But as Vapelabs frames it, that’s precisely why pharmacy is the right environment for nicotine vaping therapy.
When vaping is treated as a smoking cessation tool — not a lifestyle product — it becomes part of a clinical conversation, not a commercial one.
Patients who have tried and failed with traditional nicotine replacement therapies (NRTs) may find vaping to be a useful behavioural bridge. In this context, pharmacists are uniquely positioned to offer advice that is evidence-based, patient-centric, and free from commercial influence.
2. “I don’t have the expertise to guide patients on vaping.”
The variety of vaping products can be overwhelming — even for trained professionals. But that learning curve is being addressed with pharmacist-specific education.
As Vapelabs explains, resources like the Vapelabs Education Centre offer foundational training, clinical guides, and tools such as a Patient Weaning Chart, designed to help pharmacists support patients step-by-step through their quit journey.
For patients, this means the advice you receive is grounded in up-to-date, professional training — not guesswork or hearsay.
3. “Time constraints limit how much support we can offer.”
Pharmacy workloads are already high — and adding detailed vaping consultations can feel daunting. Vapelabs acknowledges this, highlighting their partnership with QuitHub, which helps automate parts of the referral and prescription process.
Patients are referred to authorised prescribers, and if eligible, receive an eScript directly — reducing pressure on pharmacists while keeping the patient in a clinical loop.
This allows pharmacists to stay engaged without being overburdened, and ensures patients remain on a structured cessation pathway.